FIELD: pharmaceutical industry. SUBSTANCE: an active component of the developed composition for injection is a drug - glucosamine hydrochloride. Medicinal form for intramuscular and intraarticular injections has two ampoules A and B. Solution A (ampoule of 2 ml volume) has 20-% glucosamine hydrochloride, 0.5% anesthetic substance and stabilizing agent. Solution B (ampoule of 1 ml volume) has 0.6-% buffer solution. Developed composition retains stability during preparing and storage. EFFECT: improved properties of composition.
Authors
Dates
1998-08-27—Published
1996-05-06—Filed